Anti-Inflammatory Effects of Rosiglitazone in Patients With Stage 4 and 5 Chronic Kidney Disease
Status:
Withdrawn
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study in patients with stage 4 and 5 chronic kidney disease is to
determine whether rosiglitazone can reduce inflammatory markers and to investigate its effect
on intima media thickness, calcification and pulse wave velocity.